Upstate Active Clinical Trials
Study Title:EA5181: Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Upstate Institutional Review Board (IRB) Number:1610017
Patient Age Group:Adults
Principal Investigator:Stephen L Graziano, MD
What is involved if I participate?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
Where will the study take place?Upstate- all procedures
Oswego- all procedures
Oneida- all procedures
The Hill- radiation therapy
Who can I contact for more information?
Name: Eunice B Awuah, PhD